Clinical Trial: Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Double-blind Placebo Controlled Trial Using Pentoxifylline Associated With Pentavalent Antimony in Cutaneous Leishmaniasis

Brief Summary: The purpose of this study is to determine whether pentoxifylline associated to pentavalent antimony has a higher cure rate than pentavalent antimony alone in the treatment of cutaneous leishmaniasis.